Clinical Trials Directory

Trials / Completed

CompletedNCT03514680

Clinician Decision Support Algorithm for Chemotherapy-Induced Peripheral Neuropathy

Evaluating a Clinician Support Algorithm to Enhance Implementation of Evidence-Based Chemotherapy-Induced Peripheral Neuropathy Assessment and Management Recommendations

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
226 (actual)
Sponsor
Dana-Farber Cancer Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This research study is evaluating how well a decision support tool works to improve clinicians' use of recommended chemotherapy-induced peripheral neuropathy (CIPN) assessment and management strategies in participants receiving chemotherapy.

Detailed description

This research study will test a new clinician decision support tool for the assessment and management of CIPN. The algorithm is designed to help clinicians make decisions about which strategies to use for the assessment and/or management of CIPN. The investigators need to recruit participants receiving chemotherapy that is known to cause CIPN to determine how well the algorithm works to increase clinicians' use of recommended CIPN assessment and management strategies.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCIPN Assessment and Management AlgorithmThe revised algorithm incorporates evidence-based CIPN assessment and management strategies and standardized CIPN/pain patient-reported outcomes measures. In terms of processes, trained study staff will administer the screening questionnaires (e.g., PRO-CTCAE, 0 - 10 numerical rating scale of worst CIPN pain intensity) to consented patients before their clinician visit (e.g., in the waiting room). Following patient completion of the screening questionnaires, study staff will provide the clinicians with a color-coded summary of the patients' responses to the screening questionnaires and the CIPN assessment and management algorithm. Clinicians may then use the algorithm at their discretion to guide the assessment and management of their patients' CIPN symptoms

Timeline

Start date
2018-06-04
Primary completion
2019-12-30
Completion
2020-03-23
First posted
2018-05-02
Last updated
2022-03-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03514680. Inclusion in this directory is not an endorsement.